|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-6-21
|
|
pubmed:abstractText |
The risk of relapse after autologous bone marrow transplantation (ASCT) is high and is related to the type of malignancy and phase of the disease. The outcome for the patient who relapses after an autologous transplant is poor. Some of these patients achieve a remission with conventional chemotherapy, but it is usually short-lasting. Most of them succumb to the original disease. One further therapeutic possibility is an allogeneic transplant which would confer the potential advantage of a graft-versus-leukemia effect in addition to the lack of tumor contamination of the graft and to a high-dose intensity conditioning regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:BacigalupoAA,
pubmed-author:BerissoGG,
pubmed-author:BreganteSS,
pubmed-author:BruniDD,
pubmed-author:DominiettoAA,
pubmed-author:FrassoniFF,
pubmed-author:GualandiFF,
pubmed-author:LamparelliTT,
pubmed-author:MordiniNN,
pubmed-author:RaiolaA MAM,
pubmed-author:Van LintM TMT,
pubmed-author:di GraziaCC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
646-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11418375-Adolescent,
pubmed-meshheading:11418375-Adult,
pubmed-meshheading:11418375-Aged,
pubmed-meshheading:11418375-Blood Donors,
pubmed-meshheading:11418375-Female,
pubmed-meshheading:11418375-Hematologic Neoplasms,
pubmed-meshheading:11418375-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11418375-Humans,
pubmed-meshheading:11418375-Karnofsky Performance Status,
pubmed-meshheading:11418375-Male,
pubmed-meshheading:11418375-Middle Aged,
pubmed-meshheading:11418375-Recurrence,
pubmed-meshheading:11418375-Transplantation, Autologous,
pubmed-meshheading:11418375-Transplantation, Homologous,
pubmed-meshheading:11418375-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
|
|
pubmed:affiliation |
Dipartmento di Ematología, Ospedale San Martino, Genoa, Italy. emato2@smartino.ge.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
